Founded: 2003  |  Investment Year: 2025  |  Headquarters: Neumünster, Germany  |  Founders: Konstantin Wree, Oliver Lau, Thomas Piehl

AlfaVet Tierarzneimittel GmbH is a German specialty veterinary pharmaceutical company producing medicines, feed supplements, and care products for both companion and farm animals. More than two decades of operating history have given the company a research-driven approach paired with its distinctive “power of nature” philosophy — integrating herbal and natural ingredients into modern veterinary formulations. Its products are distributed exclusively through veterinary practices, pharmacies, and specialist wholesalers across Germany and the wider European market.

Sofico’s investment in AlfaVet extends its international healthcare portfolio into the veterinary sector — a resilient, fast-growing segment of global life sciences supported by rising pet ownership, premiumization, and increasing regulatory sophistication. Through capital support and strategic cooperation, Sofico aims to reinforce AlfaVet’s research capabilities, support new product development, and facilitate cross-market collaboration between European innovation and emerging growth markets.